Cambrex Corporation acquired Q1 Scientific Limited.

Cambrex Corporation (Cambrex) is a United States-based small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle. The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. The Company offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and potent application program interface. In addition, it also supports conventional dosage forms including oral solids, semi-solids and liquids and has the capabilities to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.